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ABSTRACT 
Preterm infants are at risk for oxidative stress just by being born. The extra-uterine 
environment is relatively oxygen-rich, their antioxidant defenses are immature, diseases and 
treatments in the neonatal period will trigger inflammatory responses. The cellular effects of 
preterm birth and the impact on immune development are incompletely understood. 
The main focus of this thesis is trying to understand the cellular mechanisms of how preterm 
birth affect the adaptation to extrauterine life. The four papers included involve different 
aspects of environmental exposures in children delivered preterm; telomere length, 
inflammation and lung function (paper I), viral respiratory infections and cellular aging using 
the biological markers telomere length (telomere attrition rate) and predicted DNA 
methylation biological age (paper II), immune system development and environmental 
exposures (paper III), and hyperoxia-induced lung damage in an experimental model and the 
capacity to counter-act surfactant inactivation with a novel antioxidant (paper IV). 
We found that telomere length was similar in 10-year-old children born preterm with a 
history of BPD and term born children with allergic asthma. Impaired lung function with low 
forced expiratory capacity and male gender were associated with short telomeres 
irrespectively of preterm birth (paper I). Despite early exposures to risk factors, preterm born 
children had preserved telomeres and showed no accelerated epigenetic aging during the first 
2 years of life (paper II). Measurements of immune system states that cord blood was not 
representative of postnatal immunity. The immune system of preterm and term children 
differed at birth but unexpectedly converged early in life and followed a shared stereotypic 
pattern of adaptation to environmental exposures. Microbial interactions drive early immune 
system development (paper III). Hyperoxia impaired surfactant function and this could not be 
prevented by an antioxidant, N-Acetylcysteine amide, however the antioxidant did not affect 
surfactant function or treatment effect (paper IV).  
We have developed new sampling methods allowing us to perform comprehensive 
measurements from minimal blood sample volumes, particularly important in preterm infants 
with small blood volumes. The resulting “neonate-omics” permits global assessments of 
immune system composition to be related to biochemical pathways and epigenetic 
modulations.  
In conclusion, preterm birth was not associated with increased cellular aging, suggesting 
active repair mechanisms compensating for neonatal stressors. Exogenous surfactant is a 
vehicle for antioxidant treatment to the lung. We describe for the first time the immune 
adaptation to environmental exposures early in life. With a better understanding of the 
challenges for a baby born far too early and much too small comes the possibility to develop 
individualized treatments and modify care to ensure not just survival, but future health. 
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1 BACKGROUND 
1.1 PREMATURITY 
1.1.1 Definitions and prevalence 
Complications of preterm birth caused ~1 million deaths in the world in 2015 and was the 
leading cause of death among children under five years of age to the World Health 
Organization 3. One in 10 children are born preterm, which is defined as birth before 37 
completed weeks of gestation: 
• extremly preterm: less than 28 weeks of gestation 
• very preterm: 28+0 to 31+6 
• late to moderate: 32+0 to 36+6  
Sometimes the definitions used are based on birth weight instead 4: 
• low birth weight (LBW): < 2500 grams 
• very low birth weight (VLBW): < 1500 grams 
• extremly low birth weight (ELBW): < 1000 grams 
Suggestions from WHO in order to save 75% of preterm babies involve the implementation 
of essential care for both mother and child at birth and postnatally, provision of antenatal 
steroid injections to mothers at risk of preterm delivery, kangaroo mother care and antibiotics 
to treat newborn infections.  
 
Figure 1. Global causes under-5 deaths in 2015. Source: WHO 3 
Around 115 000 children are born in Sweden per year, the incidence of preterm birth is less 
than 6% and 1% of infants are born very preterm. A Swedish population-based study of 
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infants born alive, prior to 27 weeks of gestation between the years 2004 and 2007, the 
EXPRESS study, reported an overall one-year survival of 70% 5. 
1.1.2 Short term lung morbidity 
Immature lungs are still a major cause of mortality and morbidity in infants born extremely 
preterm and in the Swedish cohort 25 % developed severe bronchopulmonary dysplasia 
(BPD) 6. The use of antenatal steroids, postnatal surfactant treatment, improvements in 
ventilation treatments and nutritional care have ameliorated morbidity for extremely preterm 
born infants, but the incidence of BPD has not decreased 7. Definition of BPD is still based on 
a dependency of excess oxygen at 28 days of life and then its severity is graded at 36 weeks 
of gestation 8. Discussions are of a redefining of this disease. Previously BPD was caused by 
barotrauma and oxygen toxicity but today it is more considered a condition caused by an 
arrested normal lung growth and vascularization together with an inflammatory milieu in the 
preterm baby and an important influence of persistent patent ductus arteriosus (PDA) 9-11. 
Oxidative stress plays an important role in triggering cell apoptosis, in serving as second 
messenger and a mediator in signal transduction. Oxidative stress can trigger cellular and 
molecular changes in the lung that leads to permanent changes in the lung anatomy. Many 
efforts have been made to prevent BPD or reduce its severity, but the lack of a clear 
pathophysiology is hampering such progress. 
1.1.2.1 Ventilation strategy to prevent lung injury 
Mechanical ventilation is known to cause structural effects on lung development in preterm 
infants 12 and a meta-analysis show that more non-invasive ventilation strategies reduce BPD 
incidence 13. Mechanical ventilation, as oxidative stress, can induce inflammation with 
cytokines being released from macrophages and neutrophils 14. Inhaled nitric oxide (NO) 
could help advance lung development in animals, but NO treatment in preterm infants have 
not reduced incidence or mortality caused by BPD 15,16. This despite some reports have 
shown a reduction in some inflammatory markers in tracheal aspirates after NO treatment 17. 
1.1.2.2 Treatments to reduce BPD 
BPD incidence have been shown to be reduced by several other treatment strategies such as 
caffeine 18, vitamin A injections 19 and insulin growth factor-1 (IGF-1) infusions 20. We know 
that trace elements serve as important co-factors of antioxidants and improved nutritional 
status will improve the balance between catabolism and anabolism in the preterm baby and 
reduce BPD incidence as well as another important complication, retinopathy of prematurity 
(ROP) 21. The pathophysiology of BPD is multifactorial and clearly there is still not “one 
treatment” that will prevent all cases of BPD. 
1.1.3 Long term morbidity 
Prematurity is emerging as a risk factor for morbidity also in adult life and the risk for 
elevated mortality is ~ 40% 22,23. There is a growing body of evidence for morbidity 
suggesting increased incidence of cardiovascular diseases 24-27 as well as metabolic diseases 
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28-30. The overall physical performance is reduced and correlates with gestational age, preterm 
birth and low birth weight 31,32. 
Respiratory conditions in childhood as well as later in life during adulthood, in children with 
BPD, involve airway obstruction, hyper-responsiveness and hyperinflation 33-35. Children 
born in the last two decades had better lung function as a reflection of better neonatal care but 
still show signs of obstruction, particularly in the small airways, and a hyper-responsiveness 
36-40. Impaired lung function was still evident as a consequence of extremely preterm birth 
even without being diagnosed with BPD 41-43. 
1.2 ADAPTATION TO EXTRAUTERINE LIFE 
The stress of being born is greater than any other challenge we meet in life. Transition from 
fetal life means adjustment of circulation, regulation of body temperature, metabolic changes 
and start of respiration. The fluid filled lungs will by the first few breaths need to be a 
sufficient provider of oxygen and remove carbon dioxide to ensure adequate ventilation. The 
gas exchange take place in the smallest part of the lung, the alveolus, and for its optimal 
function and stabilization the alveoli needs surfactant. When the lung opens up, the 
pulmonary resistance falls and pulmonary circulation increases. The main purpose for the 
blood circulation is to deliver nutrients and oxygen to all cells and remove carbon dioxide and 
other waste products. For an optimal oxygenation of all cells in the body the collaboration 
between the lung tissue and the blood flow is essential. 
1.2.1 Facing the environment 
The lung, the gastrointestinal tract and the skin are our interfaces with the world surrounding 
us and these interfaces are constantly exposed to the environment. These tissues, the lung 
epithelium, the gut mucosa and the epithelial layers of the skin all serve as barriers to protect 
us and interact with the environment. A well-adapted such environmental interaction is 
necessary for survival. This environmental interaction will occur irrespectively if born 
preterm or term, and therefore immaturity of these systems will affect the ability of a child to 
interact appropriately. It can be harmful but also serves as an opportunity for us as physicians 
to intervene. We still do not fully understand how the micro-environment affect our cellular 
responses and trigger our surveillance mechanisms and the responses of our immune system. 
1.2.1.1 Lung 
The lung matures during fetal life and a preterm lung consists of 150 million alveoli with a 
surface of around 3-5 m2. An adult has a lung surface of around 80-100 m2 and 300 million 
alveoli 44. When the extremely preterm born infant meets the environment the lung 
development has reached a late canalicular stage or early saccular stage and the development 
of the alveoli is incomplete. Alveolarization is the process of forming new alveoli and 
normally occur postnatally like the development of the pulmonary vascular tree, 
vascularization. The capillaries develop and grow around the alveoli. This process is 
regulated by hormones and cytokines important for cell growth and differentiation. The 
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respiratory epithelium will be exposed to the environment and disturbances of both 
alveolarization and vascularization can be part of the development of BPD and pulmonary 
hypertension 45,46. 
The airways are covered with an epithelium that produce mucus, about 20 ml per day (in 
adults). This is the first line of defense against microbes removing pathogens and debris by 
the ciliary escalator. The sodium and chloride content are about the same as in plasma and pH 
acidic (6.8). The epithelial lining fluid contain antioxidants (glutathione, ascorbic acid, uric 
acid) and other biochemicals that together with macrophages and neutrophils are part of the 
innate immunity that protects us from the environment. 
1.2.1.2 Pulmonary surfactant 
The pulmonary surfactant is essential for the adaptation of the lung and for respiration. 
Surfactant will stabilize the alveoli during respiration by lowering the high surface tension of 
the air-liquid interface and without this gas exchange will be insufficient. Exogenous installed 
surfactant in preterm infants with respiratory distress syndrome is life-saving 47. Surfactant 
also have important functions for innate immunity. Surfactant is produced by type II alveolar 
cells and consist of 90% lipids and 10% proteins and are essential for decreasing the surface 
tension and stabilize the alveoli during respiration, especially surfactant protein B and C 48. 
The surface activity of surfactant depends on gestational age and the phosphatidylcholine 
content 49. 
The antioxidant capacity of surfactant increases with greater phospholipid content of which 
plasmalogens and polyunsaturated phospholipids are particularly important 50. Activity of the 
two important free radical scavengers superoxide dismutase and catalase is present in 
surfactant. These scavengers were also found being active in naturally derived surfactant used 
for exogenous surfactant treatment 51. 
Surfactant proteins also have properties important for immunity. Surfactant protein A and D 
are so called collectins and will bind to sugars on the surface of pathogens to facilitate 
phagocytosis and inhibit proliferation as part of the innate immune system 52,53. SP-A have an 
important role in reducing type II alveolar cell apoptosis 54. SP-D also have an anti-
inflammatory effect binding directly to toll-like receptors (TLRs) involved in the innate 
immunity. The lipid content is 85% phosphatidyl choline (PC) of which the major part is 
saturated in the dipalmitoylated form (DPPC). The rest of the lipid content are 
phosphatidylglycerol, cholesterol and free fatty acids. Lipids have function in the immune 
system 55,56 and hyperoxia reduces phospholipid production of surfactant 57,58. 
1.2.1.3 Gastrointestinal tract 
The surface area of the gastrointestinal tract in adults is around 30-40 m2 and serve as another 
large interface with the environment along with the lung 59. The mucosa is filled with blood 
and lymphatic capillaries embedded in the connective tissue covered by an epithelial lining. 
The gut-barrier will absorb nutrients and promote passage of molecules and signaling 
  5 
molecules important in maintaining the homeostasis of endocrinal, neuronal and 
immunological processes. Acidity in the stomach serve as one barrier of protection against 
microbes along with a production of secreted factors covering the mucosal lining amounting 
to and around 7 liters a day (adults) that will pass through the gastrointestinal tract 60. 
1.2.1.4 Micro-environment 
In late stages of gestation a rapid elevation in activity (>150%) in the antioxidant enzymes 
occur, much like the increases seen in the surfactant system as it prepares for the transition 
from the intrauterine environment to extrauterine life 61. These adaptations are an 
evolutionary advantage when the newborn child meets normoxia after birth in contrast to the 
“physioxia” during fetal life. Every tissue has its own optimal partial pressure of oxygen, 
“physioxia” 62, that during fetal life represent a much lower partial oxygen pressure than in 
air. Oxygen level in air is 21% (partial pressure of 160 mmHg) and in the body it differs from 
zero to 19%. Oxygen level is almost 0% in the lumen of the gastrointestinal tract 63 were 
many commensal anaerobic bacteria constitutes the microbiome. In the airways oxygen level 
normally have around 19% of oxygen in the upper airways down to levels around 15% (110 
mmHg) in the alveoli. In venous blood pO2 is 40 mmHg (5%) and in arterial blood 100 
mmHg (13%) normally. At birth the infant will transition from hypoxia to normoxia, that can 
be described as a hyperoxic challenge. 
The cells lining the mucosa and the respiratory epithelium have the ability to attract 
macrophages, chemokines and work with signaling both between and within cells. Processes 
of attracting immune cells, phagocytosis, opsonizing, both active and passive transportations 
through cell membranes are at work. When the local environment change, the repertoire of 
responses to the environment changes and one example of that is different reactions to 
oxygen. 
Surfactant is synthesized by type II alveolar cells already in utero and the lungs reach 
sufficient surfactant pools around gestational week 32-34. Born prior to that will cause 
surfactant deficiency, but within a couple of days after birth, the surfactant production is 
drastically enhanced. Term infants have a surfactant pool of 100 mg/kg while preterm have 
around 5 mg/kg. The laminar bodies recycle most of the surfactant from the alveolar space 
back to the pneumocytes. Half-life is around 10-15 hours. Through exocytosis (transporting 
out from the cell) the laminar bodies carry surfactant that form a tubular myelin net when 
excreted on the surface of the air-liquid phase. 
1.2.2 Exposure to oxygen 
1.2.2.1 Reactive oxygen species 
Oxygen is necessary for survival, but it can also be toxic. Reactive oxygen species (ROS) 
are important for many cellular mechanisms including intracellular signaling, growth and 
organ development but are also important for the immune system and our defense against 
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microbes 64. However, an excess of ROS can be harmful and cause DNA damage, lipid 
peroxidation and protein degradation (Figure 2). 
 
 
 
 
 
  
 
 
Figure 2. Reactive oxygen species are essential to life, but can also be toxic. If the antioxidant capacity is 
overwhelmed by production of ROS, oxidative stress will occur, the unbalance between pro-and 
antioxidants. 
The production of ROS occurs normally in the mitochondrial respiratory chain when 
oxygen is reduced to water and in the process form the oxygen radical superoxide (O2-.), 
hydrogen peroxide (H2O2) and hydroxyl radicals (OH.). Oxygen radicals are also 
produced in different enzymatic systems of which the hypoxanthine-xanthine oxidase 
system might be of particularly importance in newborn infants 65. The activation of 
neutrophils and macrophages is also associated with the release of mediators such as 
lysozymes, peroxidases, proteases, as well as oxygen radicals and nitric oxide as a mode 
of defense against pathogenic bacteria. Ceruloplasmin and transferrin are potent 
antioxidants, but when iron is oxidized (Fe2+ to Fe3+) the most potent oxidant in the 
biological system, the hydroxyl radical, is formed through the Fenton reaction 66: 
Fe2+ + H2O2                 Fe3+ + OH. + OH- 
The antioxidant system can under normal conditions counter-act normal ROS production, 
but when there is an imbalance between ROS production and the capacity of the 
antioxidant system we get oxidative stress. 
1.2.2.2 Antioxidant defense 
A compound that can donate a single uncoupled electron to a free radical will have an 
antioxidant capacity and be part of the defense against free radicals. Some antioxidants are 
produced during normal metabolism in the body but some needs to be supplemented by our 
diet. Vitamin A, C and E, beta-carotene as well as bilirubin and selenium are important non-
enzymatic antioxidants and half of the antioxidant capacity in human blood comes from uric 
ROS 
BAD 
• lipid peroxidation 
• protein degradation 
• DNA damage 
• cell death 
 
GOOD 
• organ development/growth 
• regulatory mechanism 
• intracellular signaling 
• defence against microbes 
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acid. Enzymatic scavengers like superoxide dismutase (SOD), catalase and glutathione 
peroxidase play a major role in the intracellular defense. 
Glutathione (GSH) is the most important intracellular antioxidant and consists of the amino 
acid glutamate, cysteine and glycine. Glutathione peroxidase (GPx) catalyzes the reaction 
converting hydrogen peroxide to water and molecular oxygen, a reaction otherwise mainly 
driven by catalase. In the same step GSH is oxidized to GSSG (glutathione disulfide). The 
oxidized form of glutathione (GSSG) will be reduced by NADPH (nicotinamide adenine 
dinucleotide phosphate) back to GSH (Figure 3) and the ratio of GSH/GSSG is a used marker 
of oxidative stress. 
 
H2O2 + 2 GSH           GSSG + 2 H2O 
GSSG + NADPH + H+             2 GSH + NADP+ 
 
Figure 3. The oxidation-reduction pathway of glutathione. Glutathione peroxidase (GPx) oxidize glutathione to 
form GSSG and with the presence of NADPH glutathione reductase (GR) will catalyze the reaction to regenerate 
GSH. Glutathione is kept mainly in its reduced form in erythrocytes important for cell membrane stability and 
protection against ROS-induced damage. 
1.2.2.3 Oxidative stress 
Oxygen toxicity leads to DNA damage and even brief periods of excess oxygen exposure at 
birth have been associated with childhood cancer 67,68. On the other hand, Northway et al 69 
showed in a newborn mouse model that inhibition of DNA synthesis by 100% oxygen 
exposure had a major effect on lung growth and cell replication but was reversal in contrast to 
adult mice of whom all died. This imply an adaptive capacity for cellular survival in the 
immature lung. Solberg et al showed in a piglet model of hypoxia that resuscitation with 
oxygen (40%, 60% and 100%) would in a dose-dependent manner increase oxidative stress 
and oxidation of DNA 70 and that hyperoxia may lead to genetic instability. Another reason 
for different responses to oxidative stress might be reduced antioxidant capacity due to lack 
of substrates, for instance cysteine, but treatment with infusions of amino acids the first days 
of life could not reduce oxidative stress even though levels of glutathione were increased 71. 
Neonatal animal might resist mortality to oxygen exposure but the lung will be damaged and 
normal lung development changed into a phenotype similar to BPD, as recently described in 
an overview by Silva et al 45. 
Hyperoxia leads to cell destruction, edema and inflammation. The different response to 
hyperoxia in an adult tissue compared to a neonatal or preterm tissue suggests different ways 
of signaling in the cells. Either cell death by necrosis/apoptosis or cell survival, but then often 
with consequences of structural changes or inflammation. That means to an altered 
development of the neonatal preterm lung, leading to long term consequences, explaining 
some of the pathophysiology of bronchopulmonary dysplasia. 
GPx 
GR 
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1.2.2.4 Oxidative-stress induced morbidity 
Preterm infants are at risk for oxidative stress just by being born. The extra-uterine 
environment is comparable rich in oxygen (PO2 100 mmHg) compared to intra-uterine life (20 
mmHg). They are often exposed to chorioamnionitis and inflammation already in fetal life 
and need treatment with supplementary oxygen causing hyperoxia after birth. Increased ROS 
production due to elevated levels of free iron and the immaturity to respond to the oxidative 
stress 72 will put the preterm infant at high risk for free-radical induced damage and 
inflammation 73. Also, the fact that preterm birth also occurs as a consequence of 
inflammatory and infectious diseases in the mother, increases the risk of elevated ROS in 
preterm children. The free radical disease in the neonatal period was first established by 
Saugstad in 1988 65. Even though the pathophysiology still is not fully understood, oxidative 
stress will contribute to the diseases of prematurity such as BPD, ROP, NEC, IVH and PDA 
74 75-77. 
Children born preterm, irrespectively of BPD diagnosis or not, had signs of oxidative stress 
along with impaired lung function at 15 years of age when compared to healthy controls 78. 
Consequences of resuscitation or treatment with supplementary oxygen showed oxidative 
stress measured as different aspects of the glutathione metabolism 79-83. 
1.2.3 Innate immune system in neonates 
The first lines of defense meeting the environment are cells of the innate immune system. 
This aspect of immunity is ready to go immediately at birth and does not require memory 
formation and interaction with specific antigens to evolve. The immunological barrier can be 
described as mechanical, chemical and microbiological. The mechanical defenses consists of 
the epithelia cells with the flow of air and fluid across the epithelium and the movement of 
mucus by ciliary function. The chemical defense consists of fatty acids, enzymes, low pH and 
antibacterial peptides. The microbiological defense here means having a non-pathogenic 
normal flora of microbes that will compete with the pathogens for survival. For instance, the 
microbiome can be called “an organ within the organ” because it can execute enzymatic 
reactions that the body itself cannot catalyze 84. 
Another key defense strategy of the innate immune system is phagocytosis. Lung resident 
macrophages are the first to engulf the pathogens, but neutrophils will also help out. These 
cells will release granules containing enzymes and peptides that will be part in mediating this 
very intricate antibacterial response moving from extracellular compartment to intracellular 
action (Figure 4). 
The immune responses can differ depending on the micro-environment, that is, which 
compartment or tissue involved, the oxygen level, substrates available and also maturation of 
the organ. The cascades of reaction can differ during developmental stages in life, the fetus 
will react differently compared to newborn infants and adults. The reactions in extremely 
preterm born infants are therefore difficult to predict. Some important factors involved in the 
preterm innate immune system are listed below. 
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Figure 4. Phagocytosis is a key effector mechanism of the innate immune system. 
1.2.3.1 Hypoxia inducible factor (HIF) 
Hypoxia-inducible factor (HIF) is a protein complex with two subunits a and b that regulates 
transcription of over 100 genes important for regulation of cellular stress and metabolism 
sensitive to different oxygen levels 85. During physiological oxygen levels (normoxia) HIFs 
are hydroxylated by proline hydroxylases and constantly degraded. Hypoxia leads to 
translocation of HIF-1a to the nucleus and together with HIF-1b they form a complex with 
DNA to regulate transcription of genes involved in many different processes (angiogenesis, 
erythropoiesis, apoptosis, glucose metabolism, pH regulation, proteolysis, cell proliferation 
and survival), all of which are important during fetal life and for organ development. Hypoxia 
inducible factor is the key regulator of homeostasis for cell survival in a poorly oxygenated 
environment. 
HIF-1a accumulation activates vascular endothelial growth factor (VEGF) expression 
promoting the angiogenesis and the vasculogenesis 46,86. Hyperoxia to preterm lambs caused 
a dramatic decrease in levels of HIF-1a and HIF-2 a and disrupted VEGF expression 
implicating that disrupted HIF and VEGF expression in the lung may contribute to BPD 87. 
The micro-environment of an infected tissue is often hypoxic. The HIF levels in macrophages 
and neutrophils will increase when the cells encounter the more hypoxic tissue than when 
phagocytes 
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enzymes 
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circulating in well-oxygenated blood. Pathogens invading the tissue will activate TLRs that 
recognize shared microbial components, such as lipopolysaccaride, LPS, on gram-negative 
bacteria. This TLR activation will often trigger the upregulation of HIF via the NFkB 
pathway. These bactericidal and proinflammatory processes are enhanced and apoptosis 
inhibited in favor of cell survival. HIF will thereby promote the phagocytotic capacity in 
tissue of the infection, but not in healthy tissue where it could cause damage to the host cell. 
HIF also regulate other intrinsic immune responses and will enhance functions of immune 
cells such as dendritic cells, mast cells and epithelial cells in the skin, gut and respiratory 
epithelium 88. As another example, in response to the respiratory syncytial virus, RSV, HIF 
expression has been shown to be induced and VEGF production increased leading to an 
increased blood vessel permeability and edema central to the clinical presentation of RSV 
pneumonia 89. In these ways, these key components TLRs, NFkB and HIF, form a network 
that intersect hypoxia, inflammation and immune defense and are of importance to many of 
the complications facing children born preterm. 
1.3 BIOMARKERS AND ANTIOXIDANTS 
1.3.1 Markers of oxidative stress 
Biomarkers for oxidative stress are difficult to measure because free radicals have a very 
short half-life. Instead more stable products of the free radical damage on lipids, proteins and 
nucleic acids are measured (Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Known biomarkers of free radical damaged lipids, proteins and DNA respectively 76. 
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The ratio of GSA/GSSG, to measure the amount glutathione that are oxidized is a technical 
challenge, and the biological processes work so fast that it will be difficult to sometimes 
interpret the result. Even so, it is one very central marker of oxidative stress and have been 
used in many studies. High levels of lipid hydroxyperoxide and low levels of GSH was 
correlated to mechanical ventilation and found in broncheoalvolar lavage fluid in preterm 
infants with BPD in comparisons to preterm infants without BPD 90. 
1.3.2 N-Acetylcystein amide (NACA) 
N-acetyl cysteine (NAC) is a well-known and clinically widely used thiol antioxidant that 
functions as a potent scavenger of free radicals and facilitates the production of the 
intracellular antioxidant glutathione by reducing extracellular cystin to cysteine. When the 
carboxyl group of NAC is replaced with an amide group N-acetylcysteine amide (NACA) is 
formed, a molecule that is neutral in charge with more lipophilic properties and thereby have 
better penetration trough membranes including the mitochondria and the blood-brain-barrier. 
NACA restores cellular glutathione, have a potent metal chelating activity and prevent 
oxidative stress 91,92, resulting in a stronger biological effect than NAC 93,94.  
There are different suggested mode of action for the thiol compound N-Acetylcysteine amide 
(NACA). In a mouse model of asthma NACA attenuated airway inflammation using the 
NFkB pathway to inhibit VEGF and Th2 cytokine production and reduced hyper-
responsiveness 95. NACA could prevent cell death by blocking the p38 MAPK/iNOS singling 
pathway in vitro and that was confirmed in vivo in a rat model of contrast-induced 
nephropathy 96,97. 
 
1.4 AGING 
1.4.1 Telomeres 
Telomeres are non-coding DNA sequences (TTAGGG) surrounded by telomere binding 
proteins, that stabilize the end of the chromosomes. The telomeres shortens with each cell 
division due to the end-replication problem 98 and telomere length may therefore reflect cell 
Figure 6. The suggested anti-inflammatory role of N-
Acetylcysteine amide (NACA) by inhibiting NFkB 
and HIF-1a which leads to suppression of VEGF and 
Th2 cytokines.  
The red circles represent possible mode of action   
of NACA. 
Published by permission of Sunitha et al., 2013, Free 
Radical Research 2 
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division history. Telomere length shortens faster when exposed to oxidative stress 99,100 and is 
a marker of accelerated cellular aging 101,102. Telomere attrition rate could be slowed down in 
vitro by antioxidant treatment 103. 
There is a great variability of telomere length between individuals but also within the same 
individual. At the same time, the telomere length correlate between different tissues within an 
individual. Therefore, telomere length in hematopoietic cells can serve as a surrogate marker 
for telomere length in other tissues 104. 
SIRT1 is a nicotinamide adenine dinucleotide-dependent deacetylase that regulate different 
proteins involved in processes like inflammation, angiogenesis, production of ROS and 
senescence. Preterm birth was associated with low levels of SIRT1 and showed increased 
senescence 105. Critically short telomeres may induce cellular senescence and thereby reduce 
the risk for unrepairable DNA damage. The tissue functions are influenced by the frequency 
of senescent cells. The pathway of signaling is not clear but stabilization of p53 involved in 
mitochondrial function and increased expression of p21 and SIRT1 has been suggested. 
Telomere dysfunction affect transcription factors that will activate p53 and result in 
mitochondrial dysfunction (metabolism, biogenesis, defective ATP generation and increased 
ROS production). If the mitochondrial respiration were mildly inhibited the pathways of 
longevity are activated, while pronounced impairment would trigger functional decline and 
aging 106. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Pronounced impairment of mitochondrial function will promote inflammation and senescence. SIRT1 
function as a metabolic sensor and can link the energy status of the cell to regulate gene expression and 
epigenetic changes. 
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Short telomeres have been linked to age related diseases in adults 107-110. Studies of telomere 
length and prematurity in relation to disease are scares but there are evidence of short 
telomeres associated to psychological stress in children 111-113 or in metabolic conditions 114. 
Similar telomere length was found in a study of telomere length and lung functions 115 in a 
preterm cohort compared to term born children. Preterm born infants have longer telomeres at 
birth compared to term 116-118. There is still no answer whether preterm born individuals 
exposed to high levels of oxidative stress will age faster. 
At birth humans have a telomere length of around 10 000 base pairs (bp) in their blood cells, 
around 3000 at 35 years of age and 1500 bp at 65 years of age. The entire chromosome has 
150 million base pairs. On average a cell divides normally 50-70 times during its life time 
and at each division loose 30-100 bp 119-121. 
Telomere length feature an oscillating dynamic pattern 122 which levels out over time (Figure 
8), but the underlying mechanisms has still not yet been unraveled 123. Females tend to have 
longer telomeres than males. 
 
Figure 8. Svenson et al proposed the hypothesis of dynamic changes in telomere length over time 122. 
The attrition of telomere length will differ in tissues but also during the course of life. The 
attrition rates vary in different age groups. Adults shortens their blood cell telomere length 
with ~30 bp/year, while children have been described to reduce theirs with 300 to 1000 
bp/year 124,125. The attrition rates in children seem to plateau around four years of age 126. In 
preterm newborn infants the rate can be up to 270 bp/week 127,128.  
1.4.2 Telomerase 
Telomerase is a ribonucleoprotein reverse transcriptase enzyme that maintains the telomere 
length by adding telomeric repeats to the end of chromosomes 129. The telomerase complex 
contains several subunits including the telomerase reverse transcriptase (hTERT), its RNA 
component (hTERC) and associated proteins including dyskerin. Telomerase activity is high 
during fetal life, but decreases rapidly after birth except for in stem cells and in germline 
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cells. Telomerase plays a role in promoting cell growth and cell survival, and has shown to be 
active in signaling and mitochondrial function 106 and protect cells from oxidative stress 
130,131. Telomerase activity was shown to be dynamic when adults were exposed to acute 
stress that gave a rise to increased cortisol levels, but also a significant increase in telomerase 
activity within one hour of the stress-exposure 132. These findings imply that the decline of 
telomere length in hematopoietic cells can be reversed under specific circumstances and in 
response to specific stimuli.  
1.4.3 DNA methylation 
DNA consists of the different nucleotides thymine, guanine, cytosine and adenine. Our genes 
can be switched on or off by different mechanisms whereby epigenetic regulation is one. 
Epigenetic modifications are dynamic and may, without altering the DNA sequence, silence 
or activate genes. DNA methylation is one epigenetic mechanism that involves the addition 
of a methyl group (CH3) to a carbon atom on a cytosine followed by a guanine (called CpG 
sites). The reaction is catalyzed by DNA methyltransferases. CpG rich areas of the genome 
are called CpG islands and are particularly sensitive for gene silencing if methylated. DNA 
methylation is an important regulator of cell functions and development but is also important 
for maintaining chromosome stability. Dysregulated DNA methylation has been associated 
with diseases, for instance in cancer. Much effort is put in trying to understand the role of 
hypermethylated and/or hypomethylated genomic regions in disease development and 
progression. Altered DNA methylation patterns can also be used as biomarkers for different 
conditions.  
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2 AIMS 
Overall aim 
To study inflammation and oxidative stress in preterm children and to better understand the 
mechanisms that triggers these phenomena aiming for future development of protective 
treatments to prevent inflammatory complications of preterm birth such as acute and chronic 
lung disease. 
Specific hypothesis and aims 
Study I 
Preterm children have longer telomeres at birth compared to term born children. We 
hypothesized that children born preterm with a history of BPD would have shorter telomere 
length, as they were exposed to neonatal inflammation and at risk of growing up with 
impaired lung function. The aim was to evaluate the consequences of preterm birth and 
bronchopulmonary dysplasia at ten years of age in regards to inflammation, lung function and 
telomere length. 
Study II 
Prematurity itself and neonatal intensive care will trigger inflammatory processes and 
oxidative stress. Telomere length is a marker of oxidative stress. We hypothesized that 
preterm birth results in faster telomere attrition rate. The aim was to study if cellular aging, 
measured as telomere attrition rate and predicted DNA methylation biological age, was 
accelerated during the first two years of life following preterm birth and if early respiratory 
viral infections contributed. 
 Study III 
Preterm born children are susceptible to infections during the neonatal period in life. We 
hypothesized that the immune system is hampered by preterm birth due to a different cell 
composition affected by immaturity. The aim was to study the immune system during the 
first three months of life to describe the immune development in preterm and term infants 
during their immunological transition to extrauterine life. 
Study IV  
Mechanical ventilation and inflammation inactivates pulmonary surfactant. We hypothesized 
that hyperoxia-induced surfactant inactivation can be prevented and lung function improved, 
using exogenous surfactant as a vehicle for treatments with an antioxidant. The aim was to 
study the consequences of hyperoxia on pulmonary surfactant in a preterm rabbit model and 
if inactivation of surfactant could be prevented by adding an antioxidant (N-Acetylcysteine 
amide) to the exogenously instilled surfactant treatment. 
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3 MATERIALS AND METHODS 
3.1 SUBJECTS AND STUDY DESIGN (PAPER I, II AND III) 
This thesis involves three clinical studies (I-III) with three different study cohorts and each 
cohort was part of a larger study. Study I was a cross-sectional cohort study of ten-year old 
children while the other two studies were longitudinal cohort studies from birth and up to 
around 4 months of age (study III) or up to two years of age (study II). In all clinical studies 
the outcome is put in relation to prematurity. 
3.1.1 Paper I - Telomere length, lung function and inflammation 
This cross-sectional cohort study was part of a larger follow-up study of preterm born 
children with BPD, the Premature follow-up with Lung function Mannitol and Methacholine 
(PULMM) study 37. Children born in Stockholm County between 1998 and 1999 diagnosed 
with BPD were invited to a follow-up examination at 10 years of age. BPD was defined as 
the need for oxygen for 28 days postpartum and was graded into mild, moderate or severe at 
36 weeks corrected gestational age, according to the definition by Jobe and Bancalari 8. Mild 
BPD was defined as no breathing support, moderate BPD as the need for supplementary 
oxygen of < 30% and severe BPD as the need for supplementary oxygen of 30% or more 
and/or ventilatory support. Outpatients at the Pediatric Asthma and Allergy department at 
Karolinska University Hospital were recruited as controls and consisted of gender- and age-
matched children with allergic asthma born at term and without respiratory symptoms in the 
neonatal period. The follow-up investigations included blood sampling and lung function 
testing and all individuals with available blood sample were included in our study of which 
29 were children born preterm with a history of BPD and 28 children as controls born at term 
with phadiatop positive asthma developed during childhood (Figure 9). Perinatal information 
was retrieved from the Medical Birth Registry and neonatal morbidity parameters were 
extracted from hospital records. We analyzed relative telomere length in relation to 
prematurity, lung function and inflammation. 
 
Figure 9. Flow chart of cohort 1. 
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3.1.2 Paper II - Cellular aging and viral respiratory infections 
A subgroup of preterm born children (n=16) and term born controls (n=44) with longitudinal 
blood samples were identified from a larger longitudinal case-control study of lung function 
development during the first two years of life, the LUFT study. LUFT was a follow-up study 
of lung function in preterm and term born infants and the impact of viral infections during the 
first year of life. Eligible for inclusion in the LUFT study were infants born preterm (before 
gestational week 36+6) during January 2009 to March 2011 and admitted to one unit at 
Karolinska University Hospital. Exclusion criteria were children with major malformations or 
neurological impairment preventing later lung function testing. The control group were 
healthy children born at term (gestational week 37+0 – 41+6) on the same day as the index-
child and matched for gender and maternal smoking. The protocol included blood sampling at 
two time points; cord blood at birth and peripheral venous blood at follow-up at two years of 
age, as well as lung function evaluation at three months of age and at two years, but data from 
lung function is not reported in this thesis. Respiratory infections during the first year were 
monitored and in case of an infection also sampled. From the 197 children included in the 
LUFT study with at least one blood sample taking, we included 60 children with longitudinal 
samples for analyses of cellular aging in relation to prematurity and viral infections during the 
first year of life (Figure 10). 
 
Figure 10. The study cohort of Study II. The analyzed subgroups children from a larger cohort study of lung 
function development during the first two years of life including preterm born and matched term born children at 
Karolinska University Hospital from 2009 to 2011. Children with longitudinal blood samples available from 
both birth and at 2 years of age were included in the telomere and cellular aging analyses (Paper II). 
Cellular aging was measured with two different methods; as telomere attrition rate (n=60) 
and epigenetic aging (DNA methylation age, n=23). For selection of the smaller group to 
analyze predicted DNA methylation biological age (DNAm) we initially included matched 
pairs (10 preterm and term individuals). Due to difficulties in getting longitudinal samples 
and enough amount of extracted DNA, we included an additional 13 individuals, chosen by 
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the investigators to balance the groups for gender, parity, quarter of birth, mode of delivery 
and chronological age at follow-up. Perinatal information and neonatal morbidity data were 
retrieved from medical records. 
3.1.3 Paper III - Neonatal immune system development 
A subgroup (n=100 infants, 110 parents) from the study TELLUS (TELomeres, LUng 
disease and oxidative Stress in preterm born infants) were included (Figure 11). Inclusion 
criteria in TELLUS are children born preterm before gestational age week 30 and gender 
matched term born controls (37+0 – 41+6) at Karolinska University Hospital from April 2014 
and inclusion is still ongoing. Cord blood and placenta biopsy samples are collected at birth 
and blood, buccal cells, urine and faeces during the first four months of life (week 1, 4 and at 
term around week 12). Parental samples from blood and buccal cells are taken for hereditary 
comparisons and breast milk from mothers at every time point her child was sampled. 
Perinatal data was retrieved from medical records.  
TELLUS (TELomere LUng disease and oxidative Stress in preterm born infants) 
 
Figure 11. Study protocol of the on-going TELLUS study of which 100 infants (50 preterm and 50 term) was 
included in studies of neonatal immune system development 133. Cellular (biological) aging and oxidative stress 
will not be analyzed until the study is closed. 
For Study III we enrolled 100 newborn children born between April 2014 and July 2017 and 
used blood and fecal samples. In all we used 285 samples from 100 children, 156 samples 
from 58 mothers and 52 fathers from the TELLUS cohort. In addition, 12 samples from 3 
healthy adult controls were included. 
 
 
  
Premature 
GA < 30  
n=100 
                                           
 
 
 
 
Term 
GA 37+0 - 41+6 
n=100 
 
Analyzes: 
• oxidative stress markers in urine/blood – isofuranes/isoprostanes in urine, DNA damage 
with a single cell gel elecrophoresis (comet assay) in blood 
• relative telomere length in blood and buccal cells 
• anti-secretory factor in plasma/breast milk 
• immune system in blood 
• heredity: telomere length in blood and buccal cells in parents 
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3.2 TESTS AND MEASURMENTS (PAPER I, II AND III) 
3.2.1 Lung function (paper I) 
Dynamic spirometry performed with a Vitalograph 2120 (Ennis of Ireland, County Clare, 
Ireland) was performed to assess pulmonary function before bronchodilation in study I. 
Forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and forced 
expiratory flow (FEF) using European Respiratory Society and Polgar reference values were 
determined 134. A positive reversibility test was defined as an increase of at least 10% of 
FEV1 after 0.5 mg inhaled terbutaline. Plethysmography (CareFusion, Bavaria, Germany) 
was used to measure lung volumes: vital capacity, total lung capacity, fractioned residual 
volume and residual lung volumes. Diffusion capacity for carbon monoxide was evaluated 
using a single breath technique. Reference values of Hedenström Solymar were applied for 
static spirometry values and diffusion capacity 135. Lung function values were reported as 
percentage of predicted value. 
3.2.2 Cellular aging (paper I and II) 
3.2.2.1 DNA extraction 
Whole blood of 2 mL was collected in EDTA tubes and frozen at -80°C within one hour. 
Genomic DNA was extracted using the MagNA Pure LC instrument (Roche Diagnostics 
Scandinavia AB, Stockholm, Sweden). DNA yield and purity were determined 
spechtrophotomerically (Thermo Fischer Scientific Inc., Wilmington, DE, USA). 
3.2.2.2 Telomere length 
Relative telomere length (RTL) was determined by the quantitative polymerase chain 
reaction method described by Cawthon et al.136 with minor modifications 137. Briefly, each 
DNA was analyzed in triplicate wells in separate Telomere (TEL) and single copy gene 
(hemoglobin subunit beta, HBB, Gene ID:3043) reactions at two separate times (ABI7900HT 
instrument, Applied Biosystems). The TEL/HBB and telomere/single copy gene T/S values 
were calculated by the 2-DCt method, where DCt = CtTEL – CtHBB. Ct refers to the threshold 
cycle. The RTL value for each sample was generated by dividing the sample T/S value with 
the T/S value of a T-lymphocyte cell line called CCRF-CEM, which was used as a reference 
and included in all runs. The inter-assay coefficient of variation was between 4 and 8%. 
3.2.2.3 Relative telomere length (RTL) 
In study I RTL was evaluated cross sectional at 10 years of age in two cohorts of children 
with lung disease, preterm born children with BPD and term born children with allergic 
asthma. In study II we measured RTL at birth and at two years of age in preterm born infants 
and term born controls. The method using relative telomere length is adjusted to a reference 
DNA, but RTL-values from the different studies in this thesis may not be comparable due to 
different batches of PCR reagents. 
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3.2.2.4 Telomere attrition 
In study II we measured RTL at two time points, at birth and at follow-up at two years of age, 
and therefore telomere attrition during the first two years in life could be evaluated. Telomere 
attrition rate per year was as follows; (RTL at follow up – RTL at partus/(chronological age 
at follow up in years). 
3.2.2.5 DNA methylation 
High density arrays covering 485,577 CpG sites (HumMeth450K, Illumina, San Diego, 
USA) were used for genome-wide methylation analysis. The included CpG sites are located 
in different genomic regions, but focused on promoter-associated regions and CpG islands. 
Briefly, 500 ng DNA was bisulfite converted by the EZ methylation gold kit (Zymo 
Research, Irvine, USA). To each array, 200 ng of bisulfite-converted DNA was applied, and 
the arrays were operated according to the manufacturer´s instruction and scanned with the 
HiScan array reader (Illumina). The fluorescence intensities were extracted using the 
Methylation module (1.9.0) in the Genome Studio software (V2011.1). The quality of each 
individual array was evaluated with built-in controls. 
3.2.2.6 Epigenetic aging 
The epigenetic DNA methylation (DNAm) age was calculated based on 353 CpG sites, by 
the “epigenetic clock” prediction model described by Horvath138,139. Delta age was 
determined by subtracting the individual´s chronological age from the estimated epigenetic 
DNAm age at birth and at two years of age. Epigenetic aging (DNAm aging rate/year) 
corresponds to (DNAm age at follow up – DNAm age at baseline)/chronological age at 
follow up. Baseline in our study was birth and therefore represents chronological age 0 years. 
3.2.3 Immune system (paper I, II and III) 
3.2.3.1 Inflammation (paper I) 
In study I we evaluated inflammation using exhaled nitric oxide (FeNO) reported as part pre 
billion (Niox equipment, Aerocrine AB, Stockholm, Sweden) 140. Blood cytokines, IL-6, IL-
8, TNF-a and IL-1b, were analyzed by electo-chemiluminescence immunoassay routinely 
used by the Karolinska University Hospital Laboratory. 
3.2.3.2 Viral infections (paper II) 
In study II we evaluated exposure to viral infections during the first year of life. Respiratory 
infections were monitored. Parents kept a diary and were instructed to report to the hospital 
for clinical evaluation when their child showed symptoms of infection. Nasopharyngeal 
sampling for viral infections was performed at every infection episode and analyzed by 
routine PCR methods at Karolinska University Hospital Laboratory. The panel covered 
adenovirus, influenza A and B, parainfluenza 1, 2 and 3, respiratory syncytial virus, 
metapneumovirus, coronavirus (Oc 43, 229 E, NL 63, HKU1), enterovirus, rhinovirus, 
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mycoplasma pneumoniae and chlamydia pneumoniae. Episodes of wheeze, bronchiolitis and 
hospital admissions were reported. 
3.2.3.3 System-level immune analyses (paper III) 
Samples were taken at birth (umbilical cord blood) and then longitudinally at week 1, 4 and 
12. Samples used in study III was collected from blood and faeces. Blood ~100 µL was put in 
fixation solution (Cytodelics AB) at once and put in the -80°C freezer after 5-10 min. 500 µL 
of blood was put in an EDTA vial. The samples were centrifugated within one hour and 
plasma was extracted and put in the -80°C freezer. PBMC were extracted using a protocol 
based on Ficoll density gradient separation within two hours and prepared with freezing 
media and put in the -80°C by slow freezing for optimal cell viability. Both parents were also 
sampled accordingly at week 1 and for mothers also at week 12 after delivery. 
3.2.3.4 Mass cytometry  
System-level analyses is the application of many simultaneous measurements to describe a 
complex process involving many immune cell populations and proteins 141. For such analyses 
of individual immune cells Mass cytometry is a powerful method 142. This method is based on 
the use of about 40 different antibodies targeting intracellular and surface proteins in millions 
of individual immune cells to describe their overall phenotypes and function (Figure 12). We 
used this method to understand the neonatal immune system development in detail. We 
designed a mass cytometry panel with 38 antibodies targeting activation and differentiation 
markers across all white blood cell populations and profiled a total of 95,278,466 immune 
cells from 337 blood samples in total with as little as 100 µL of blood. 
 
 
 
 
 
 
 
 
 
 
Figure 12 A) High-dimensional cell profiling by Mass cytometry in which 38 antibodies are used to target 
proteins in millions of cells. Each antibody is coupled to a unique-mass tag that can be quantified in an IPC-MS 
type system. B) High-dimensional plasma profiling by dual-recognition and qPCR readout after DNA-ligation of 
complementary oligos. 
Figure XA) High-dimensional cell profiling by Mass 
cytometry in which ~40 antibodies are used to target 
proteins in millions of cells. Each antibody is coupled to 
a unique-mass tag that can be quantified in an ICP-MS 
type system. B) High-dimensional plasma profiling by 
dual-recognition and qPCR readout after DNA-ligation 
of complementary oligos.  
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3.2.3.5 Plasma proteins 
We used a sensitive dual-recognition immunoassay 143,144 (ProSeek, Olink, Uppsala, Sweden) 
allowing for quantification of 267 unique proteins in < 20 µL of plasma. 
3.2.3.6 Transcriptome 
We used transcriptome analyses by PBMC mRNA-sequencing at weeks 1 and 12 to 
interrogate gene expression changes occurring after birth. 
3.2.3.7 Microbiome 
We performed 16S rRNA profiling of fecal samples from 45 children collected at weeks 1, 4 
and 12 of life (n=95). 
3.2.3.8 Comprehend the big data 
The millions of data-points collected over time in the newborn children requires novel 
informatics pipelines for storage, processing and analysis. We built a relational database to 
manage all the acquired data and one relational database capturing clinical metadata. 
Analyses of cell populations by Mass cytometry involve quality control, filtering, gating on 
DNA-containing events (cells), removal of debris and classification of individual cells into 
known immune cell populations. As for plasma protein analyses, similar quality control steps 
were required and batch correction prior to integration of data types. The main method used 
to integrate cell and protein data is Topological data analysis 145 in which samples (both 
proteins and cells) are compared using correlation as a notion of similarity and placed in a 
parameter landscape that recreates early life immune system development. The remaining 
methods of analyses are described in detail in the publication and its supplementary method. 
Also, all scripts used as well as raw data are available (https://brodinlab.com/newborns/) 
3.3 THE EXPERIMENTAL RABBIT MODEL AND STUDY DESIGN (PAPER IV) 
Study IV is an experimental study using a preterm rabbit model of respiratory distress 
syndrome (RDS) conducted at the Surfactant Research Laboratory, Karolinska Institutet, 
Stockholm, Sweden. 
3.3.1 Surfactant preparations 
The surfactant used was porcine surfactant (poractant alfa, trade name CurosurfÒ) 80 mg/mL 
from Chiesi Farmaceutici, Parma, Italy. N-acetylcysteine amide (NACA) was provided by 
Dr. Glenn Goldstein (David Pharmaceuticals, New York, NY, USA). In the experiment the 
antioxidant NACA was dissolved with sodium chloride to a concentration of 100 mg 
NACA/mL and added to surfactant 80 mg/mL giving a NACA concentration of 0.4, 1.2 and 4 
mg/mL. The concentrations of NACA in the surfactant suspension are 2.5, 7.5 and 25 
mmol/L (mM) and surfactant of around 75 mg/mL. The NACA-surfactant suspension was 
prepared fresh before every experiment in room temperature. 
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3.3.2 Animal experiments 
We used a well-established model to test surfactant in mechanically ventilated preterm 
surfactant deficient New Zealand White rabbits 146 with some modifications of the protocol. 
The experiments were performed on 15 litters with a total of 110 rabbit pups with exclusion 
criteria of birth weight less than 20 or more than 40 grams (n=4), being stillborn (n=1), 
technical problems (n=2) or complications with pneumothorax (n=15), leading to an over-all 
survival of 80%. The rabbit pups were obtained sequentially by hysterotomy at a gestational 
age of 27 days (term 31 days). The pups were anesthetized with an intraperitoneal injection of 
pentobarbital sodium (0.1 mL, 6 mg/mL) and locally applied Xylocain on the throat for 
surgical preparation. After tracheotomy muscle relaxation was obtained with pancuronium 
bromide (0.1 mL, 0.2 mg/mL) given as an intraperitoneal injection and thereafter exogenous 
surfactant in the dose om 200 mg/kg was given intratracheally. The animals were placed in 
pletysmograph boxes at 37 °C connected to a ventilator system (Servo Ventilator 900 B, 
Siemens-Elema, Solna, Sweden or Stephanie, Stephan, Gackenbach, Germany) and 
ventilated at a frequency of 40/min and inspiration/expiration ratio 1:1 (Figure 13). During 
the experiments individual pressure curves, tidal volumes and electrocardiography were 
recorded using a Powerlab system (AD Instrumental Limited, Chalgrove, Oxfordshire, UK) 
including Powerlab 4/20 (ML840), Bridge AmpT (ML110), Animal Bio Amp (ML136) and 
Spirometer (ML140). The animals were sacrificed at the end of the experiment with an 
intracerebral injection of lidocaine (2%, 0.5 mL) leading to an instant heart arrest and death. 
 
 
 
Experiment 1: Preterm rabbits (n=27) were treated at birth with 0.5, 1.5 and 5% NACA in 
surfactant. Animals receiving the same dose of surfactant served as positive controls and non-
treated littermates as negative controls. The surfactant dose was 200 mg/kg. The newborn 
rabbits were ventilated in parallel with standardized sequence of peak inspiratory pressures 
(PIP). To open up the lungs, pressure was first set at 35 cmH2O for 1 min. After this 
recruitment maneuver, pressure was lowered to 25 cmH2O for 15 min, 20 cmH2O for 5 min 
and 15 cmH2O for another 5 min. Finally, pressure was raised again to 25 cmH2O for 5 min. 
The experiments were performed without positive end-expiratory pressure (PEEP). 
Figure 13. Newborn rabbits ventilated in 
parallel in plethysmograph boxes using 
individualized peak inspiratory pressures 
to achieve tidal volume of 6-8 mL/kg. 
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Experiment 2: The animals were randomized to mechanical ventilation with either 21% 
(n=10) or 100% oxygen (n=11) and treated with porcine surfactant (200 mg/kg). The treated 
animals were ventilated for 90 min with a PEEP of 3-4 cmH2O and individualized peak 
inspiratory pressure to achieve a tidal volume of 6-8 mL/kg. The untreated control animals 
(n=3) were only ventilated for 30 minutes. Some animals received surfactant and was not 
ventilated (n=6) to serve as a baseline for what ventilation can cause to oxidative stress 
markers. 
Experiment 3: The animals were randomized to mechanical ventilation with 100% oxygen 
and treatment with surfactant (n=15) or 1.5% NACA in surfactant (n=13). The treated 
animals were ventilated for 60 min with a PEEP of 3-4 cmH2O and individualized PIP to 
achieve a tidal volume of 6-8 ml/kg. The untreated controls were ventilated for 30 min (n=2) 
and one animal served as baseline. 
3.4 TEST AND MEASUREMENTS (PAPER IV) 
3.4.1 Lung compliance and lung gas volume 
Dynamic lung compliance was calculated from pletysmographic pressure-volume 
registrations at 15, 30, 45, 60 and 90 minutes. Volume and pressure were recorded at start, 
10, 20, 30, 45, 60, 75 and 90 minutes. Tidal volume (Vt) was divided with peak inspiratory 
pressure and body weight. 
The lung gas volume (LGV) used in experiment 1 can also be described as the functional 
residual capacity and can be calculated by the difference between the organ volume of the 
lung and the tissue volume. By dipping the lung into water, the water will be displaced and 
the weight of that volume will represent the lung volume. Tissue volume was retrieved by 
converting the wet-weight of the lung to a volume using a constant (1.077 with standard 
deviation of 0.03). The formula to calculate LGV (mL/kg) = (lung volume (mL) – (wet 
weight (g)/1.077))/body weight (kg). 
3.4.2 Bronchoalveolar lavage 
Bronchoalveolar lavage (BAL) was performed after euthanasia by installation of 20 or 40 
mL/kg of normal saline and retracting it three times. The procedure was repeated five times 
and the washes were pooled. Aliquots of the BAL fluid was ultra-centrifugated to separate the 
phospholipids as large (LA) and small aggregates (SA) and markers of oxidative damage 
were analyzed both in BAL before centrifugation and in BAL after ultra-centrifugation in the 
LA and SA portion separately. 
3.4.3 Biophysical activity of surfactant 
Biophysical activity of surfactant was tested in vitro by mimicking the alveolus of the lung in 
the pulsating bubble surfactometer (Surfactometer International, Toronto, Canada). A bubble 
of air in contact with the surrounding was inserted in a chamber filled with surfactant and 
pulsated using a piston system. Dynamic surface tension was recorded at 37°C during 50% 
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cyclic compression of the bubble surface and at a frequency of 40 cycles per minute. All 
measurements were performed for 5 minutes and at a lipid concentration of 5 mg/mL. The 
pressure at specific time intervals were measured and using the law of Laplace the surface 
tensions at minimum (gmin) and maximum (gmax) bubble size was calculated 147. 
3.4.4 Hyperoxic damage of surfactant 
3.4.4.1 Phospholipid determination 
The phospholipids (phosphatidylcholine, lysophosphatidylcholine, sphingomyelin) were 
determined by an enzymatic method (LabAssayÔ Phospholipid, Wako Pure Chemical 
Industries, Ltd, Osaka, Japan). Surfactant have different structural forms of which around 
85% consists of more surface-active large aggregates (LA) that are involved in stabilizing the 
alveoli during breathing and degrades to smaller less surface-active aggregates (SA) normally 
during respiration. When the lung is injured the amount of SA increases leading to a 
disturbed SA/LA ratio and we used this to assess surfactant inactivation in the experimental 
model of respiratory distress syndrome and exposure to hyperoxia. Bronchoalveolar lavage 
fluid was centrifugated (40,000 x g for 60 min at 4°C) 148and phospholipid content was 
determined in BAL both before centrifugation and then in the LA and SA components 
separately. 
3.4.4.2 Lipid peroxidation 
The degree of lipid peroxidation in the BAL fluid was determined by measuring the amounts 
of malondialdehyde (MDA) and 4-hydroxyalkenals (4HNE), using a LPO-586 colometric 
assay (Bioxytech LPO-586, OXISResearch, OXIS Health Products, Inc., Portland, 
USA)149,150. The maturity can differ between litters in the animal experiments and enzymatic 
kits are known to be sensitive to react differently between batches. We compensate for this by 
calculating a score of lipid peroxidation (LPO score) using the amount of MDA per amount 
of phospholipids (mmol MDA/mg PC) for each animal divided by the mean value of the  
litter 151. 
3.4.4.3 Total proteins and protein carbonyls 
Total protein content was quantified in the BAL fluid using the BCA Protein Assay kit 
(Immundiagnostik, Bensheim, Germany). Protein carbonyls are formed through oxidation of 
proteins and was quantified by an assay using ELISA (BCA-Protein Quntification Assay for 
the Carbonyl Protein ELISA, Immundiagnostik, Bensheim, Germany) measuring carbonyls 
in micrograms of proteins. 
3.5 STATISTICAL ANALYSES 
In study I, II and IV, data are given as mean and standard deviation when normally 
distributed, and as median and interquartile range otherwise. ANOVA and independent 
sample t-tests were used for normally distributed data. Levene´s test for equality of variance 
was performed and, if significant, a t-test assuming different variance was performed. Non-
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normally distributed data were analyzed using Kruskal-Wallis´ rank-sum test. Differences 
were tested with chi-square and Fisher´s exact test for categorical data and we used Pearson 
coefficients for correlation analysis. In paper I and II linear regression was used for 
evaluating group differences between preterm and term born children using perinatal data (for 
instance maternal age, premature rupture of membrane, parity, mode of delivery, birth 
weight, BMI and gender), evaluating inflammation and lung function (study I) and postnatal 
viral infections (study II). In study I linear regression was used to analyze relative telomere 
lengths in relation to neonatal morbidity in the preterm group using an F-test for categorical 
predictors with more than two categories. 
In study II methylation data were pre-processed and normalized by BMIQ method as 
previously described 152 using R (v2.15.0). The methylation levels (i.e., the b value) of each 
CpG site ranges from 0, corresponding to completely unmethylated DNA, to 1, representing 
fully methylated DNA. 
For study I, II and IV statistical analyses were also performed using STATA version 13 
(StataCorp, College Station, TX, USA) and IBM SPSS Statistics version 25 (IBM 
corporation, Armonk, NY, USA). A p-value < 0.05 was considered statistically significant. 
Study III involves a massive dataset and hundreds of different statistical tests. All these 
analyses were performed by a team of computational biologists within our collaborator Petter 
Brodin’s research team using custom built pipelines mainly written in R and Python. All 
these methods are described in detail in paper III. 
3.6 ETHICAL CONSIDERATIONS 
For clinical studies (study I, II, III) written parental consent was obtained. Parents were 
approached after assent of the attending physician. In study III samples from cord blood and 
placenta was retrieved and if the parents decided not to participate in the study the samples 
were discharged. No samples were taken in any baby without the parents had given their 
written and oral consent. Studies in children always involve particular ethical considerations 
given that children themselves are never allowed to consent in instead represented by their 
parents. In the study all blood sampling was performed concomitant with clinical sampling 
whenever possible to minimize the number sampling procedures and the blood volume 
sampled was always kept to a minimal required to perform assay. The studies in this thesis 
was approved by the Regional Ethical Review Board in Stockholm for study I, II and III; and 
from the Animal Ethical Committee in Stockholm for study IV. 
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4 RESULTS 
4.1 PAPER I 
We related relative telomere length (RTL) to prematurity, lung function and inflammation. 
Telomere lengths were similar in 10-year-old children irrespective of a history of preterm 
birth, BPD or childhood asthma. However, there was a gender difference with females having 
longer telomeres than males at 10 years of age whether born preterm or term (Figure 14). 
  
The term born group (n=28) that developed allergic asthma during childhood had a mean 
gestational age at birth of 40 weeks and a birth weight of 3591(range 2925 to 4210) grams. 
The preterm born group with a history of BPD (n=29) had a mean gestational age of 27+1 
(23+2 – 32+5) and a mean birth weight of 1070 (607 to 2426) grams. Almost 60% had 
moderate or severe BPD, required a mean of 10 days with ventilatory support and 60% of the 
preterm infants needed CPAP more than 35 days (range 7 to 70 days). A majority received 
antenatal steroids (86%) and 62% were treated with surfactant. One third needing surgery for 
severe ROP and two thirds were treated for PDA but no infant had severe IVH (grade 3-4)153. 
More than half were diagnosed with sepsis and a majority were treated with postnatal 
corticosteroids (86%). 
RTL did not correlate to perinatal factors such as gestational age, birth weight, SGA, mode of 
delivery, parental age or parity. We found no correlations to physiological parameters at the 
age of 10 years such as age at follow-up, weight, length, BMI or blood pressure. In the 
preterm born group neonatal morbidity (ventilatory support requirements, surfactant 
administration, duration of supplemental oxygen, neonatal sepsis, IVH, ROP, PDA, severity 
of BPD) did not affect RTL. 
Lung function on the other hand, did affect RTL. Our two groups both had an impaired lung 
function at 10 years of age compared to normal reference values 134. Preterm children with 
BPD showed significantly lower results than term children with asthma for both dynamic and 
Figure 14. Relative telomere length (RTL) in 10-
year-old children in relation to gestational age and 
gender 1. 
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static spirometry. It was most pronounced in the smaller airways with reduced FEF50% (p 
<0.01) and impaired diffusion capacity (p <0.05). 
RTL showed a positive association to dynamic spirometry indices (FEV1/FVC, FEF50% and 
FEF25%) in the crude linear regression analysis but after adjusting for gender this association 
only remained significant for FEF50% (regression coefficient = 0.003, p = 0.03), and if divided 
in groups, only for the asthma group alone (regression coefficient = 0.004, p = 0.02). 
There was no difference when evaluating inflammation measuring blood cytokines (IL-1b, 
IL-6, IL-8 or TNF-a) between groups. Airway inflammation measured as fractional exhaled 
nitric oxide was more prominent in the group of children with asthma (23.7 ± 21 versus 12.2 
± 9, p <0.05) compared to the BPD group, but we found no correlation between RTL and 
inflammation. 
We concluded that blood telomere length at the age of 10 years was not shorter in children 
with a history of preterm birth and BPD compared with term born children with allergic 
asthma. Impaired lung function with low forced expiratory flows and male gender were 
independently associated with shorter telomere length.  
4.2 PAPER II 
In this longitudinal cohort study we included 16 infants born preterm with a mean gestational 
age of 31+6 and birth weight 1894 grams and 44 infants born term (40+0 weeks and birth 
weight 3517 grams). The groups were matched for gender (57% males) but cesarean section 
was more common in the preterm group (44% versus 18%). No infants were born small for 
gestational age (SGA). Ethnicity, maternal age and smoking did not differ between groups; 
noteworthy is that only two mothers in the cohort were smokers. Preterm infants were 
significantly older (chronological age) than controls at the follow-up time point, with a mean 
postnatal age of 25.6 months (range 22 to 32) compared to 22.6 months in term infants (range 
18 to 28). The expected difference in weight and BMI z-scores between preterm and term 
born infants at birth was no longer seen at two years of age. 
Neonatal morbidity was low in this rather mature preterm cohort. Only one child needed 
oxygen for more than 28 days of life, but none required supplementary oxygen or ventilatory 
support at 36 weeks corrected gestational age. CPAP was needed for a mean of four days 
(range 0 to 27) and none required mechanical ventilation. Only six infants needed 
supplementary oxygen for on average four days (range 0 to 28) and surfactant treatment was 
given to three infants (19%). No infant had IVH grade 3-4 153 or needed surgery for NEC, 
PDA or ROP. 
Preterm infants had longer RTL compared to term infants both at birth (p<0.05) and at two 
years of age (p <0.01). No gender effect was seen on RTL either at birth or at two years of 
age. We did see that preterm born females had longer telomeres than term born females at 
birth (p <0.05) and preterm born males had longer telomeres than term born males at two 
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years of age (p <0.01). RTL did not correlate to perinatal factors such as maternal age, 
premature rupture of membranes, parity, mode of delivery, birth weight or gender. 
The exposure of respiratory viral infections during the first year of life was similar for 
children in both groups (94 versus 86%), however infants born preterm required more often 
admission to hospital and had more bronchiolitis compared to the control group (p <0.01). 
Relative telomere length was, to our surprise, longer in children with infections compared to 
children without (p <0.05). 
Telomere attrition rate per year (RTL at follow-up – RTL at birth/chronological age at 
follow-up) over the first two years of life were similar for both groups. However, boys in the 
control group had an accelerated telomere attrition per year compared to boys in the preterm 
group (0.01 ± 0.1 in preterm versus -0.12 ± 0.2 in term, p <0.01). RTL did not correlate to 
any perinatal factors or to neonatal respiratory morbidity. 
Preterm infants were generally younger in predicted DNAm biological age at birth and at two 
years of age, but only statistically significant when comparing delta age (-0.13 ± 0.8 versus 
0.65 ± 0.9 years, p <0.03). Epigenetic aging showed a tendency to be slower in the preterm 
group but did not reach any statistically significance (p=0.08). There was no correlation 
between epigenetic aging and telomere attrition rate in preterm and term born infants during 
the first two years of life. 
In summary, despite early exposure to risk factors for accelerated cellular aging, children 
born preterm exhibited preserved telomeres and did not show accelerated epigenetic DNAm 
aging, suggesting active repair mechanisms compensating for stress during the neonatal 
intensive care period. 
4.3 PAPER III 
We enrolled 100 newborn children of which 50 were born preterm (< 30 weeks gestational 
age at birth) with a birth weight ranging from 458 to 1623 grams and 50 were born at term 
(37+0 - 41+6) with a birth weight from 2838 to 4655 grams. Half of the children were males 
and 51% were born with cesarean section. The mothers had a median age of 32 (range 20-43) 
and the fathers a median age of 35 (range 21-52). The healthy controls were all males and of 
age 26, 28 and 36. Preterm children were admitted to the neonatal intensive care unit for a 
median of 65 days, with frequent antibiotic exposures, an increased risk of infections and 
developed complications typical for extremely preterm born infants. Term infants stayed at 
the hospital for a few days without complications and did not receive any antibiotics. 
The main results from the longitudinal system-level analysis of the neonatal immune system 
reflecting the adaptation of newborn infants to postnatal life involves drastic changes in 
relative frequencies of diverse immune cells after birth. Preterm and term children differ in 
both cell composition and in plasma proteins at birth (Figure 15), for instance preterm 
delivery was associated with strong inflammatory response with a high expression of 
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CXCL11 and IL-8 154. Cell composition also differed between preterm and term, including a 
lower propotion of neutrophils and a higher proportion of T-cells in preterm infants. 
 
Figure 15. Protein concentrations in cord blood of term and preterm children. Differentially regulated proteins 
are marked in blue 133. (FDR=false discovery rate) 
The cell composition, plasma proteins concentrations and cell phenotypes measured in cord 
blood was not representative of postnatal immunity. We compared the measurements from 
cord blood with samples taken during the first week of life (median, day 3) and calculated 
correlation coefficients to see whether cord blood could predict the pattern of cell frequencies 
seen at day 3. We found that only 6 out of 21 immune cells correlated strongly and also only 
one out of 81 plasma proteins with known immune function could be predicted from cord 
blood in the first week of life. This unpredictability could partly be explained by the different 
sources of samples (cord blood and peripheral blood), but the difference in immune cell 
composition during the first week of life was also seen in a few children (n=7) were we had 
peripheral blood both at day 0 and from week 1. This implicates that the inability to predict 
postnatal immune systems from cord blood was not just due to samples coming from 
different tissues, but can partly be explained by the drastic changes that occur in the cell 
composition right after birth. 
Further, we were able to describe different phenotypic changes within each cell population. 
To be able to comprehend the many dimensions of single-cell data we used Barnes-Hut t-
SNE (bhSNE) to create two-dimensional embeddings of single cell data from consecutive 
time points (Figure 16). Below we show that while blood samples taken from adults with one 
week in between show remarkable phenotypic stability, the immune cell phenotypes of 
neonates were markedly different when comparing cord blood with week 1 samples. 
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Figure 16 A) bhSNE embedding indicating cells in blood samples from two consecutive weeks in an adult. B) 
bhSNE maps of immune cell phenotypes in cord blood and week 1 from a newborn 133. 
Despite drastic changes in cell composition, plasma protein concentrations, cell phenotypes 
after birth, and differences between preterm and term born infants, the immune system 
rapidly converges following a stereotypic pattern. This was illustrated by integrating all data 
(cell frequencies, protein concentrations, clinical metadata) using topological data analysis to 
visualize the changes in several different measurement modalities over time (Figure 17). 
There were no large effects of gender or season of sampling on plasma protein concentrations 
or immune cell composition throughout the study period. 
 
Figure 17. Topological landscape of neonatal immune system adaptation 133. 
A 
B 
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The convergence of preterm and term immune systems was mostly explained by changes in 
the frequencies of neutrophils and naïve CD4+ T cells, which were seen already during the 
first weeks of life. However, we performed mRNA sequencing (mRNA-seq) of viable 
peripheral blood mononuclear cells (PBMCs) comparing preterm (n=4) and term (n=4) at 
week 1 and 12 at the transcriptome level. Also, with this analysis we found that the groups 
were largely intermixed, but that gene expression differences persisted at 12 weeks 
postnatally that could distinguish preterm from term. An analysis of gene ontology (GO) 
terms associated with those genes overexpressed in preterm infants found that those genes 
were involved in the negative regulation of interferon-gamma (IFNg) production, T cell 
proliferation and IL-10 secretion. This is potentially important to explain differences in 
susceptibility to infectious diseases between preterm and term infants. 
All cell populations vary over time, but the pattern for newborn children were very dynamic 
compared to adults (Figure 18). 
 
 
Figure 18. Variation of cell populations over time in adults and infants 133. 
We are trying to understand these changes over time which is demonstrated below (Figure 
19) with specific examples of some cytokines (IL-27, IL-10, IL-8, IL-17A, IL-12B) and the 
transmembrane protein PlgR (polymeric immunoglobulin receptor). PlgR is important in 
immunoglobulin A transcytosis of epithelial cells and is thereby important in mucosal 
immunity. Patterns of the cytokines and the transcriptome data imply that the changes in the 
immune system involve metabolic pathways and important immune system processes related 
to the response to microbes exposed at the mucosal surface. 
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Figure 19. Plasma concentrations at different time points: 1=cord blood, 2=preterm early, 3=term early, 
4=convergence, 5=late (3 months) 133. 
Finally, we performed 16S rRNA profiling of fecal samples from 45 infants at week 1, 4 and 
12 (95 samples). Early dysbiosis showed a dominance of bacterial classes of Bacilli or 
Gammaproteobacteria, and more circulating endothelial cells, effector T cells populations and 
higher levels of the pancreatic exopeptidase CPA1 in their blood samples at 3 months of age. 
We suggest that microbial interactions early in life will affect the colonization of the child 
and thereby affect immune system development. 
We conclude that cord blood is not representative of postnatal immunity and that preterm and 
term born infants differ at birth but rapidly converge to a shared trajectory of the immune 
system. This trajectory follows a stereotypic pattern possibly driven by microbial interactions 
and might be hampered by early gut dysbiosis. 
4.4 PAPER IV 
The biophysical activity of surfactant in the presence of N-acetylcysteine amide (NACA) was 
tested in vitro using the pulsating bubble surfactometer and in vivo (n=31) randomizing 
animals to different concentrations of NACA-surfactant concentrations evaluating dynamic 
lung compliance and lung gas volumes. Despite high concentrations of NACA given both in 
vitro or in vivo, there were no significant effect on the biophysical properties of surfactant 
including dynamic lung compliance and lung volumes. 
We evaluated the effect of hyperoxia on oxidative stress measuring lipid peroxidation and 
structural changes of phospholipids evaluating the ratio between large and small aggregates 
(SA/LA ratio). In the normoxic group there were complications with overventilation leading 
to air leakage after 60 to 75 minutes of ventilation, which explain the better survival of 
hyperoxic animals (75% versus 64%). Despite this, hyperoxia affected the structure of 
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phospholipids showing increased production of small aggregates (p <0.05) which imply less 
surface-active surfactant and there was a tendency of more lipid peroxidation (1.4 [0.02;0.08] 
versus 1.1 [1.0;2.0]) and impaired lung functions (0.42 [0.3;0.8] versus 0.70 [0.6;0.8]). 
Finally, we wanted to evaluate if adding an antioxidant to the porcine surfactant could 
ameliorate the damage of hyperoxia in surfactant deficient animals. After the in vitro and in 
vivo experiments of NACA we used 7.5 mmol/mL of NACA in porcine surfactant 80 
mg/mL. Due to the risk for overventilation seen in the normoxic animals we adjusted the 
ventilation time to 60 minutes. All animals were ventilated with 100% oxygen and were 
randomized to receive treatment with the NACA-surfactant suspension (n=13) or to 
surfactant alone (n=15). No difference in lipid peroxidation, protein degradation, ratio of 
small to large aggregates or in dynamic lung compliance could be detected. 
In summary, treatment with NACA in the surfactant suspension did not ameliorate any 
consequences of hyperoxia that we could detect with our methods during this one-hour long 
experiment, but the surfactant function or treatment effect was not hampered and surfactant 
was not destabilized by adding NACA. 
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5 DISCUSSION 
The main focus of this thesis is trying to understand the cellular mechanisms by which 
preterm birth influence the adaptation to extrauterine life and give rise to inflammatory 
complications. The four papers included involve different aspects of environmental exposures 
in children delivered preterm; telomere length, inflammation and lung function (paper I), 
viral respiratory infections and cellular aging using the biological markers telomere length 
(telomere attrition rate) and predicted DNA methylation biological age (paper II), immune 
system development and environmental exposures (paper III), and hyperoxia-induced lung 
damage in an experimental model and the capacity to counter-act surfactant inactivation with 
a novel antioxidant (paper IV).  
The principle findings are that telomere length was similar in 10-year-old children born 
preterm with a history of BPD and term born children with allergic asthma. Impaired lung 
function with low forced expiratory capacity and male gender were associated with short 
telomeres irrespectively of preterm birth (paper I). Despite early exposures to risk factors, 
preterm born children had preserved telomeres and showed no accelerated epigenetic aging 
during the first 2 years of life (paper II). Measurements of immune system in cord blood was 
not representative of postnatal immunity. The immune system of preterm and term children 
differed at birth but unexpectedly converged early in life and followed a stereotypic pattern of 
adaptation to extrauterine environment. Microbial interactions of the environment may affect 
early immune system development (paper III). Hyperoxia impaired surfactant function in the 
experimental rabbit-model and this was not prevented by addition of an antioxidant N-
Acetylcysteine amide. The antioxidant did not affect surfactant function or treatment effect. 
As a-proof-of-concept, exogenous surfactant can serve as a vehicle for antioxidant treatment 
to the lung (paper IV). 
The methodological considerations for this thesis mainly involve patient selection bias and 
the limited sample size. The selection bias is potentially influential since we used existing 
cohorts in paper I, II and III. If there are systematic differences in their characteristics that are 
not representative of the population in general, this selection bias might inadvertently 
influence the results. The small sample size was a consideration in all papers (I-IV). 
In paper I, no healthy control group was included. Both preterm and term born children had 
an impaired lung function and this might elude the differences that potentially could be found 
in telomere length at 10 years of age. The term group diagnosed with asthma had more 
inflammation. We hypothesized that BPD was a neonatal exposure of inflammation and 
would result in shorter telomeres. With the cross-sectional study design the exposure of BPD 
as a neonatal inflammation and the exposure of inflammation due to asthma in childhood 
cannot be differentiated and might attenuate the potential differences in telomere length due 
to prematurity. Another problem was the predefined cohort and we only included those with 
an available blood sample. This could have selected a group of preterm children with higher 
burden of morbidity if the parents were more prone to have extra follow-ups. 
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The strengths with paper II were the inclusion of healthy term controls when evaluating 
cellular aging in relation to prematurity and its longitudinal design. On the other hand, there 
might be a selection bias within the control group. Families of healthy children that consent 
to participate might have a heredity for certain diseases, for instance atopy, and thereby 
introduce a factor that may affect the results. Another difficult issue in research of newborn 
children is inclusion at birth. Preterm birth is rarely planned and it is difficult to get consent 
for research in a stressful time such as at birth. A limitation in paper II are the very few blood 
samples of preterm children at birth. Out of 197 available children for inclusion only 60 
children, of which 16 were born preterm and 44 were born term, had longitudinal samples. It 
was a challenge to get samples from birth in the preterm group. On the other hand, the drop 
out for follow-up samples in the control group was much higher than in the preterm group. 
Relevant for paper III were the same limitations with selection bias described above being 
part of a larger cohort study, but one strength was the inclusion frequency of more than 90% 
of available families. In studies including big data the problem with interference needs to be 
addressed. 
The strength with an experimental study is the possibility to control for all factors. The 
biological relevance of findings in an animal model needs to be interpreted with caution 
before applicable to humans. One major limitation in paper IV was the protocol of ventilation 
that gave a short exposure to hyperoxia (one hour) and that was too short to find any 
detectable differences between groups treated with an antioxidant added to exogenous 
surfactant or not. 
The considerations of study design are important due to the challenges of performing 
studies in extremely preterm infants early in life. Paper II and III had a longitudinal study 
design involving the exposure of neonatal intensive care. Extremely preterm born children 
can serve as a biological model of oxidative stress. However, the individual differences of 
both morbidity and the time of exposure of neonatal intensive care varies. Studies in humans 
are difficult to control because of the variations of individuals, but on the other hand the 
results will often be of biological relevance. 
We study the exposure preterm birth and the obvious control group would be term born 
children with full health. Exposing healthy subjects for evaluation of lung function after 
mannitol and methacholine provocation were considered an ethical problem and therefor no 
healthy controls were included in paper I. Another problem with healthy controls is to get the 
consent of longitudinal blood sampling in children, particularly infants, and this was one of 
the challenges in paper II. Blood is a great resource for sampling. However, an extremely 
preterm infants has a total blood volume of 50 to 100 mL, compared to adults who has 
approximately 5 L, and it is difficult to longitudinally sample blood in extremely preterm 
children for research. The impact of environmental exposures postnatally and hereditary 
factors for consequences on immune development and cellular aging needs to be addressed. 
The study population of paper III was part of the TELLUS study. We have developed new 
blood sparing sampling methods that allowed us to perform comprehensive measurements 
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from small blood volumes, particularly important in preterm infants with small blood 
volumes. The resulting “neonate-omics” 155 permits improved assessments of global immune 
system data, biochemical and epigenetic data, and interactions in between. 
The relevance of the findings  
Telomeres and biological aging after prematurity 
There seem to be a dynamic pattern of telomere length 122 and telomerase activity 132, but we 
still do not understand how this is regulated. We found longer telomere lengths in preterm 
born infants both at birth and at two years of age compared to healthy born term infants, 
which is consistent with others 116-118. On the other hand, we found no difference in telomere 
length at 10 years of age due to prematurity (paper I), but that was a study without any 
healthy controls and of small sample size. Hadchouel et al found no difference in telomere 
length at 15 years of age in children born preterm or healthy term born 115. 
To our surprise, the telomere attrition rate was not accelerated in the preterm group during the 
first two years of life (paper II), and telomere length remained significantly longer in preterm 
infants at two years of age. From other studies we know telomere attrition rate plateaus at 
around four years of age 126, and maybe we have a very plastic time window from birth to 
four years of age where telomere length can be affected by different exposures such as 
inflammation and oxidative stress. Acute stress exposure led to an increased telomerase 
activity 132 and the TERT subunit of telomerase protected mitochondria from oxidative stress 
131. Telomerase activity might counter-act accelerated telomere shortening during this time, 
and therefore no difference of telomere length due to prematurity in teenagers was found. 
Hadchouel et al 115 found a correlation of shorter telomeres to impaired lung function, which 
was consistent to the findings in paper I 1. 
The biological age of an individual can be estimated by DNA methylation analysis and we 
used the 353 CpG sites “epigenetic clock” prediction model described by Horvath 138,139. 
When comparing biological age to chronological age, preterm children were generally 
biologically younger than term children both at birth and at two years of age. This suggests 
that preterm children do not exhibit an accelerated cellular aging inspite of the susceptibility 
to oxidative stress damage and exposures to more severe viral infections during the first year 
of life. This might imply active repair mechanisms compensating for the stress of neonatal 
intensive care and the added stress following exposure to respiratory viral infections during 
the first year of life.  
A major limitation to paper I and II are the lack of information of cell composition in the 
blood samples. The changes in telomere length and DNA methylation pattern can differ 
depending on cell composition. Wang et al found a great intra-individual variation in DNA 
methylation pattern during the first two years in life and they identified a pattern of 
methylation located in genes associated with biological functions including immunity and 
inflammation 156. De Goede et al showed that granulocytes and T-cells exhibit inter-
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individual variability and differences in DNA methylation might not reflect prematurity but 
rather cell composition 157. 
The development of the preterm immune defense 
The focus in paper III was to understand the developing neonatal immune system in the 
transition from intrauterine to extrauterine life. The preterm infants are born into a “cytokine 
storm”. Surprisingly the immune system of preterm and term infants rapidly converges onto a 
shared trajectory. That was surprising to us considering that extremely and very preterm 
infants were admitted to neonatal intensive care, sometimes for the whole study period, and 
term healthy newborns were discharged to home within 2-3 days of life. Analyses of the 
microbiome revealed that early gut bacterial dysbiosis could hamper the normal development. 
Arrieta et al proposed that the first 100 days in life were a critical period for the impact of 
microbial dysbiosis that was associated with the development of asthma 158. For normal lung 
development a fine-tuned regulation seems to be required involving pathways such as the 
MAP kinases 159 and inflammation can be part of disrupting this normal development 160. 
Zasada et al described the genes involved in the development of the immune system of 
preterm infants during the first month of life (day 5 and 28) and concluded that despite 
differences in gestational age the pattern of gene expression was closely linked to 
postconceptional age. In the mucosal defense of newborn infants IgA is important 161 and are 
transmitted to the newborn infant by breast feeding. In the preterm infant genes important for 
host defense were activated, and most sensitive for gestational age differences were Ig A 
production in the intestine and signaling through the T-cells receptor pathway 162. 
There are studies on the development of cell composition early in life and also the 
comparison of preterm compared to term children 157,163. However, our study is the first study 
to prove a systems-level analysis across all cell populations present in the blood and that 
enables us to explain the interplay among all these different cell types early in life 133. 
Oxidative stress and lung function in experimental prematurity 
Oxidative stress, inflammation and cellular aging are all involved in pathways important for 
cell survival, cell growth and cell death. If the cell survives it might be at a cost with triggered 
inflammation. Pathways involving regulation of NFkB, MAPK (p38) and HIFs are important 
pathways in preterm infants that are exposed to oxidative stress and inflammation, and make 
the link to senescence 164,165. Some of these pathways are important for lung development 159. 
NFkB is one of the main regulators of early inflammatory responses. Hyperoxia will induce 
its activation and offer protection for the cell. NFkB play a physiological role in the 
developing lung and by regulating VEGF has an important role in both alveolarization and 
vascularization. Inhibited NFkB disrupted normal lung development in neonatal mice 166 and 
suggests a mechanism contributing to the development of BPD. Different reactions to the 
NFkB receptor have been associated with different susceptibility to develop BPD, asthma 
and bronchiolitis 160. TLRs are abundant in the airway epithelium and important to recognize 
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the action of pathogens and can modulate the response after lung injury of which activating 
NFkB is one. Surfactant protein A reduce cytokine expression and SP-D will inhibit the 
cytokine production of NFkB along with recruiting polymorphonuclear neutrophilic 
leukocytes by suppressing the TLR signaling 167. 
Great efforts have been put to try to prevent the development of BPD and the consequences 
of hyperoxia on lung impairment. Recombinant SOD given intratracheally increased the 
antioxidant capacity and decreased lung inflammation 168 without benefits to respiratory 
outcome. N-acetylcysteine (NAC) given intravenously did not reduce BPD 169,170. Natural 
surfactant has both antioxidative and immunological properties. Hyperoxia can inactivate 
surfactant and impair the antioxidant capacity. 
In paper IV we used the antioxidant compound N-acetylcysteine amide in an experimental 
model of acute respiratory distress and hyperoxia in preterm rabbits. NACA is a precursor to 
glutathione, the most potent intracellular antioxidant, and have a good capacity to cross 
membranes. It has shown good results on protecting cells from oxidative damage, but also in 
several animal models protecting both the brain, kidney and eye 91,92,96,97,171-174. NACA could 
prevent pulmonary inflammation by reducing infiltration of neutrophils and decreased the 
accumulation of ROS 175. A reduction of ROS was seen in a mouse model of asthma where 
NACA also diminished inflammatory damage in the lung by regulating the NF-kB and 
hypoxia-inducible factor-1a (HIF-1a) activity 95. Other antioxidants have been added to 
surfactant before 150,176-178. 
In our model the biophysical properties of porcine surfactant were preserved both in vitro and 
in vivo with different concentrations of NACA. The hyperoxia-induced surfactant 
inactivation could not be prevented by NACA. As a proof-of-concept, exogenous surfactant 
can serve as a vehicle for antioxidant treatment to the lung. 
Treatments with an antioxidant needs to be considered carefully. The repercussion of very 
complex systems may interact with inflammation and immunological responses. It is 
necessary to find a biomarker that indicates which child should benefit of antioxidant 
treatment. Cellular aging is faster early in life compared to later in childhood or in adulthood 
and we still do not completely understand why. The results from our studies in understanding 
the consequences of environmental exposure after birth and the cellular mechanisms 
involved, suggests that the neonatal period in life can serve as a “window of opportunity” for 
treatments preventing oxidative stress and inflammation. 
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6 CONCLUSIONS 
The immunological adaptation to extrauterine life are driven by microbial interactions and 
converge to a stereotypic pattern irrespectively of gestation. Preterm birth was not associated 
with increased biological aging (cellular aging), suggesting active repair mechanisms 
compensating for neonatal stressors. We need global analysis to understand the pathways and 
balances of the processes within the cells when exposed to microbes, inflammation and 
hyperoxia. A better understanding of this will help us identify infants with the need for 
treatments to prevent inflammation and cellular unbalances. Using exogenous surfactant as a 
vehicle to get an antioxidant for treatment of hyperoxia-induced lung damage locally might 
be feasible in the future.  
Study I 
Telomere length were similar in 10-year-old children born preterm with a history of BPD and 
term born children with allergic asthma in contrast to the proposed hypothesis. Impaired lung 
function with low forced expiratory capacity and male gender were associated with short 
telomeres irrespectively of preterm birth. 
 
Study II 
Children born preterm have early exposures to risk factors for accelerated cellular aging. 
Despite that, in contrary to the original hypothesis, preterm born children preserved telomeres 
and showed no accelerated epigenetic DNAm aging. This suggests the possibility of active 
repair mechanisms compensating for stress during the neonatal period. 
 
Study III 
Cord blood was not representative of postnatal immunity. The immune system of preterm and 
term children differed at birth but unexpectedly converged early in life and followed a 
stereotypic pattern of adaptation to extrauterine environment. This adaptation to microbial 
interactions of the environment may affect early immune system development. 
 
Study IV 
Hyperoxia impaired surfactant function in preterm surfactant-deficient rabbits, but this was 
not prevented by addition of the antioxidant N-Acetylcysteine amide. NACA did not affect 
the surfactant function and treatment effect. This is as a-proof-of-concept that exogenous 
surfactant can serve as a vehicle for antioxidants to the lung. 
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7 FUTURE PERSPECTIVES 
This thesis will not have a direct impact on saving lives, it will try to understand the 
mechanisms of how preterm birth affects the adaptation to extrauterine life on a cellular level. 
The knowledge of interactions between inflammation and oxidative stress after preterm birth 
and the consequences of aging might facilitate the understanding of risk factors for age-
related diseases and other inflammatory conditions. This will be important tools in the 
development of new medications and treatments. Preterm birth is emerging as an important 
risk factor for age-related diseases. Early preventions are necessary and the neonatal period 
might serve as an important “window-of-opportunity” to set the trajectory to cell survival 
without inflammation. 
Systems-wide analysis provide us with the possibility to identify “panels” of pathways and 
processes in relation to cell composition involved in certain conditions, such as BPD. 
Analyzing the perinatal and morbidity data, together with food exposures and immunizations 
taking the hereditary aspects into account can create “panels”. These panels may in the future 
differentiate between healthy or medically compromised infants and serve as biomarker of 
certain conditions. In the future, a flow cytometry apparatus bedside at the neonatal intensive 
care unit might help the clinicians to decide whether a child needs antibiotics or not, or when 
the optimal time point for vaccination occurs to get the best immune response.  
The development of blood sparing methods with a sampling protocol available around the 
clock and with facilities to prepare the samples at the neonatal intensive care unit was 
developed and described in paper III. One key issue has been the collaboration between 
clinical personal and researchers. We have this knowledge of how to use to systems-wide 
analysis using blood sparing protocols, the so called “neonate-omics” 155 and this can be 
systematically applied in other areas of interest and research.  
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8 SWEDISH SUMMERY – SVENSK SAMMANFATTNING 
 
 
För tidigt födda barn (prematur) löper en stor risk att exponeras för oxidativ stress. Att lämna 
den skyddande miljön i livmodern för världen utanför, utgör en dramatisk miljöförändring för 
alla barn, men särskilt för barn födda prematurt. Foster utvecklas normalt i en relativt 
syrefattig miljö medan världen utanför är rik på syrgas. Skyddande antioxidativa system är 
omogna och både infektioner och behandlingar som prematurfödda barn behöver aktiverar 
inflammatoriska reaktioner. Vi förstår ännu inte de cellulära konsekvenserna av att födas för 
tidigt men oxidativ stress och inflammation spelar en nyckelroll. 
I denna avhandling utforskar jag dessa fenomen hos prematurfödda barn. De fyra studierna 
kretsar kring olika aspekter av det för tidigt födda barnets anpassning till postnatal miljö. Vi 
studerar telomerlängd, lungfunktion och inflammation (studie I), cellulärt åldrande och 
virusinfektioner (studie II), det neonatala immunsystemets utveckling (studie III) och syrgas-
inducerad lungskada och potentiering av surfaktant-skydd med hjälp av ett 
antioxidationsmedel (studie IV). 
Vi har funnit att telomerlängden hos 10 åriga barn är jämförbar mellan barn födda för tidigt 
med utvecklad BPD under nyföddhetsperioden och fullgångna barn med utvecklade allergisk 
astma under barnaåren. En försämrad lungkapacitet och manligt kön var associerat till kortare 
telomerer oavsett gestationsålder (studie I). Mycket för tidigt födda barn bibehåller sina 
telomerlängder utan accelererat cellulärt åldrande (biologiskt åldrande) under de första två 
åren i livet (studie II). Immunförsvaret i navelsträngsblod förutsäger inte postnatala 
immunförsvaret på grund av dramatiska förändringar tidigt i livet. Dessa tidiga förändringar 
drivs av interaktioner mellan mikrober och följer ett stereotypt mönster i alla barn (studie III). 
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Syrgas-inducerad inaktivering av surfaktant i vår experimentella modell kan inte förhindras 
av en antioxidant, N-Acetylcysteine amide (NACA), men det påverkar inte heller funktionen 
av exogent tillfört surfaktant (studie IV). 
I dessa studier har jag och mina kollegor utvecklat nya provtagningsmetoder för mycket små 
blodvolymer vilket möjliggör longitudinella studier med upprepade provtagningar även hos 
de allra minska barnen. De mest avancerade mätmetoderna kan nu kombineras till ett sorts, 
”neonate-omics”, för global utvärdering av immunförsvaret och dess många olika 
signalvägar. 
Med en bättre förståelse för det nyfödda barnets utmaningar när det föds mycket för tidigt, 
kan vi utveckla nya och mer individuella behandlingar samt anpassa vården, inte bara för att 
öka överlevnad, utan också överlevnad med framtida hälsa för våra allra minsta patienter.  
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